ARTICLE | Company News
ARYx gastrointestinal, cardiovascular news
March 14, 2011 7:00 AM UTC
ARYx said it would wind down operations after FDA delayed for the second time to July a response to an SPA submitted for a Phase III trial of naronapride ( ATI-7505) to treat gastrointestinal disorder...